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2. SUMMARY 1 
Background: Pregnant women and infants under 6 months old are at risk of influenza-related 2 
complications. Limited community-based data exists on the burden of respiratory viruses for 3 
both groups. 4 
Objectives: To determine the incidence and risk factors of influenza-like illness (ILI), severe 5 
acute respiratory infection (sARI) and virus-positive cases (influenza A, influenza B and RSV) 6 
among pregnant women and infants under 6 months. 7 
Design: Prospective and observational open cohort study. 8 
Participants: All pregnant women and children less than 24 weeks old who reside in 9 
Baganuur district (バガヌール地区), Mongolia from October 1st 2013 - April 30th 2014 and 10 
October 1st 2014 - April 30th 2015 (two consecutive influenza seasons). 11 
Data collection: ILI and sARI cases were identified by scheduled follow-up calls twice a week. 12 
For those identified, clinical information was collected and influenza and Respiratory 13 
Syncytial Virus (RSV) were tested by point-of-care test kits (QuickNaviTM – Flu + RSV, Denka 14 
Seiken Co. Ltd, Japan).  15 
Statistical analysis: Overall and stratified (by trimester for pregnant women and age group 16 
for infants) incidence rates were calculated. Cox proportional hazard regression was used to 17 
analyze the risk factors of infection. 18 
Results: A total of 1260 unvaccinated pregnant women were enrolled, whereby 174 (13.8%) 19 
ILI and 2 (0.2%) sARI cases were detected. From all tested ILI (94.8%) and sARI (100%) cases, 20 
26 ILI and 1 sARI case tested positive for influenza A. The overall incidence rates for ILI, sARI 21 
 
 
4 
and influenza A were 11.8 [95% confidence interval (C.I): 11.2 – 12.4], 0.1 [95%C.I: 0.0 – 0.4], 22 
and 1.7 [95% C.I: 1.5 – 1.9] per 1,000 person-days, respectively. Incidence rates and adjusted 23 
hazard ratios for ILI and influenza A were lowest in the third trimester. Pregnant women 24 
with co-morbidity were 1.4 times more likely to develop an ILI episode [Adj.HR: 1.4 (95%C.I: 25 
1.1–1.9)]. 26 
A total of 1304 infants under 6 months were enrolled, whereby 246 (18.9%) ILI and 255 27 
(19.6%) sARI cases were detected. The overall ILI and sARI incidence rates were 15.2 [95%C.I: 28 
14.5 – 15.8] and 20.5 [95%C.I: 19.7 – 21.3] per 1,000 person-days, respectively. Among the 29 
tested ILI (77.6%) and sARI (30.6%) cases, the overall positivity rates for influenza A, 30 
influenza B and RSV were 6.3%, 1.1%, and 9.3%, respectively. Positivity rates of influenza A 31 
and RSV tend to increase with age. sARI cases were 1.4 times more likely to be male [Adj.HR: 32 
1.4 (95%C.I: 1.1–1.8)]. From all influenza A and RSV positive infant cases, 11.8% and 68.0% 33 
were respectively identified among sARI hospitalized cases. 34 
Conclusion: Low overall influenza A burden in both groups was observed, though 35 
underestimation was likely due to point-of-care tests used. For infants, RSV burden was 36 
more significant than influenza A. These findings would be useful for establishing control 37 
strategies for influenza and RSV in Mongolia.      38 
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3. BACKGROUND 39 
3.1. BASIC INTRODUCTION TO INFLUENZA VIRUS 40 
Influenza viruses are enveloped, single-stranded, negative sense, segmented, ribonucleic 41 
acid (RNA) viruses belonging to the Orthomyxoviridae family [1]. They are classified into 42 
three genera or types (A, B, and C). Genus Influenza virus A has one species, influenza A. It 43 
includes all avian and equine influenza viruses, and most influenza viruses of swine. This 44 
virus can be classified into subtypes, based on the surface glycoproteins: haemagglutinin 45 
(HA), and neuramindase (NA). There are 16 HA (H1-16) and 9 NA (N1-9) recognized subtypes. 46 
Genus Influenza virus B has one species, influenza B, which is less common than influenza A 47 
and infects mainly humans. It can be divided into two antigenically and genetically distinct 48 
lineages: B/Yamagata and B/Victoria. Influenza B mainly causes disease for school-aged 49 
children [2]. Lastly, genus Influenza virus C has one species, influenza C, which is the least 50 
common than the other types. It usually causes mild disease in children, and it can also 51 
infect dogs and pigs. Out of the three types, Influenza A and B viruses are known to cause 52 
influenza epidemics in humans, leading to significant morbidity and mortality.  Giving the 53 
rich source of host reservoirs mainly from birds and swine, influenza A viruses are able to 54 
cause epidemics and pandemics through re-assortment and mutation processes. The five 55 
known influenza pandemics occurred in 1918 A(H1N1) Spanish flu, 1957 A(H2N2) Asian flu, 56 
1968 A(H3N2) Hong Kong flu, 1977 A(H1N1) Russian flu and 2009 A(H1N1) Swine flu. 57 
Influenza B, on the other hand, has lesser chance of causing pandemics. 58 
The risk groups for influenza who are recommended to get vaccinated include those who are 59 
at risk of developing severe disease (children < 5 years old, pregnant women, the elderly, 60 
and individuals with underlying medical conditions such as HIV/AIDS, asthma and chronic 61 
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heart or lung diseases), and those at risk of getting exposed to the virus (health-care 62 
workers) [3]. 63 
3.2. BASIC INTRODUCTION TO RESPIRATORY SYNCYTIAL VIRUS (RSV) 64 
Human RSV is a non-segmented negative-sense, single-stranded, enveloped RNA virus 65 
belonging to the Paramyxoviridae family, genus Pneumovirus genus and Pneumovirinae 66 
subfamily [4]. It is divided into two major antigenic subgroups, A and B that tend to co-67 
circulate in a given season. Humans are the only host for RSV. As there is incomplete 68 
immunity upon RSV infection, multiple re-infections can occur throughout life. It is known 69 
that most children will experience at least one RSV infection by the age of two years old [5]. 70 
Primary infection with RSV is usually symptomatic, and the disease severity decreases with 71 
each subsequent exposures. 72 
The risk factors for severe RSV disease include medical conditions like premature birth, 73 
having chronic lung disease of prematurity, neuromuscular disease, congenital abnormalities 74 
of the airway, cystic fibrosis and immuno-deficiencies [5]. There are also social, demographic, 75 
and environmental risk factors: age < 6 months, young siblings in the household, daycare 76 
attendance, low birth-weight, exposure to tobacco or other air pollutants, family history of 77 
asthma, and multiple births [5]. 78 
3.3. INFLUENZA AND RSV BURDEN FOR PREGNANT WOMEN 79 
Pregnant women are known to be at high risk of influenza-associated morbidity and 80 
mortality, particularly during the pandemic periods. During the 1918 A(H1N1) Spanish flu  81 
pandemic in the United States, 27% of the pregnant women died from pneumonia [6]. A 82 
case series study in Minnesota reported that 1957 A(H2N2) Asian flu pandemic accounted 83 
for 19.2% of all deaths among pregnant women. Also, half of all women of reproductive age 84 
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who died during this period were pregnant [7]. Similar trend can also be seen with the 85 
recent influenza pandemic (H1N1) 2009, where pregnancy is associated with increased risk 86 
of influenza-associated hospitalization and death [8, 9]. Pregnant women with 87 
A(H1N1)pdm09 infection were about seven times more likely to be hospitalized and two 88 
times more likely to die, when compared to non-pregnant women of reproductive age [8].  89 
There were also reports on increased risk of influenza-associated hospitalization during the 90 
inter-pandemic period, especially among pregnant women with co-morbidity [10] and 91 
asthma [11, 12]. Women in the third trimester also have increased risk of influenza-92 
associated hospitalization, particularly if they have co-morbidities [13, 14]. When compared 93 
to post-partum women, women in their third trimester of pregnancy were 3 – 4 times more 94 
likely to be hospitalized for an acute cardiopulmonary illness during the influenza season 95 
[14]. On the other hand, studies using databases from Kaiser Permanente Health Plan in 96 
Oregon [15] and Northern California [16] reported low hospitalization rates for pregnant 97 
women during the 1975-79 and 1997-2002 seasons, respectively. During the inter-pandemic 98 
period, there is also one study that investigated the occurrence of influenza-like illness (ILI) 99 
episodes at each pregnancy stage [17]. They found increasing risk of developing ILI with 100 
increasing trimester stage, with highest risk during the post-partum period.          101 
 Influenza infection during pregnancy is also associated with poor pregnancy outcomes, in 102 
both pandemic [6, 7, 9] and inter-pandemic [18, 19] periods. Such outcomes include 103 
spontaneous abortion, preterm birth, fetal distress, caesarean delivery, small for gestational 104 
age, and low birth weight. During the 1918 H1N1 influenza pandemic, half of the cases who 105 
developed pneumonia had spontaneous abortion [6]. Pre-term birth and emergency 106 
caesarean deliveries were also reported during the pandemic (H1N1) 2009 [9]. 107 
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Unlike influenza, RSV infection among pregnant women is not much explored. To my 108 
knowledge, there has been no such study ever conducted previously. This is not unusual, as 109 
RSV disease severity is known to be low among young adults, whom must have already been 110 
exposed to RSV at a young age. RSV infection among young working adults was previously 111 
studied, but the attack rate was lower and symptom severity was milder than those for 112 
infants [20].  113 
3.4. INFLUENZA AND RSV BURDEN FOR INFANTS UNDER 6 MONTHS 114 
The burden of acute lower respiratory infections due to influenza virus [21] and RSV [22] is 115 
known to be high globally among children < 5 years old. Globally, RSV is the most common 116 
cause of childhood acute lower respiratory infections (ALRI) and major cause of 117 
hospitalizations due to severe ALRI [23]. Infants under 6 months were found to have 118 
relatively high incidence of influenza in Bangladesh [24] and the United States [25], as well as 119 
RSV in Kenya [26]. 120 
Hospitalization rates for severe acute respiratory infection (sARI) are also known to be high 121 
globally among children < 5 years old [23]. Among these children, those under 6 months old 122 
have high hospitalization rates related to influenza and RSV. In the United States, the 123 
influenza-related hospitalization rate was estimated to be 4.5 per 1,000 children under 6 124 
months old [27], while that due to RSV was 16.9 per 1,000 children [28]. Healthy infants and 125 
young children are also still at risk of either influenza- [29] or RSV- [28, 30] related 126 
hospitalizations.    127 
Young male infants are known to be at risk of sARI, leading to hospitalizations [23, 31, 32]. 128 
Male gender is also a known risk factor of severe RSV disease [33]. When compared to 129 
females, young male infants tend to have reduced airway function [34, 35] and also tend to 130 
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be more susceptible to infection [36]. The former was also reported for young males who 131 
were born full term [34, 35] and premature [37]. 132 
Although young children who were born premature and/or born with low birth weight are at 133 
risk of severe RSV-related disease [5], there are also reports on RSV burden among 134 
previously healthy young children [28, 30]. These studies enrolled infants from two different 135 
settings: hospital and outpatient [28], and randomized clinical trial [30]. This suggests that 136 
intervention strategies for RSV should consider both high-risk and healthy children.    137 
3.5. PHYSIOLOGICAL AND IMMUNOLOGICAL CHANGES DURING PREGNANCY 138 
Anatomic and physiological changes during normal pregnancy and they occur at the 139 
cardiopulmonary, immunological and hormonal levels [38, 39]. At the cardiopulmonary level, 140 
the diaphragm is elevated to accommodate the uterus, which results in up to 40% increase 141 
in tidal volume and up to 20% decrease in the functional residual capacity in the later stages 142 
of pregnancy. These changes, along with an increase in in oxygen consumption, result in a 143 
predisposition to respiratory infections and severe disease during the later stages of 144 
pregnancy [40].  145 
At the immunological and hormonal levels, the body goes into a unique immuno-modulated 146 
state whereby different immune responses occur depending on the stages of pregnancy [41]. 147 
In the early stages of pregnancy, uterine natural killer (uNK) cells and uterine dendritic cells 148 
(uDC) are necessary for blastocyst implantation and placentation processes to occur 149 
successfully. Thus, elevated numbers of NK cells and DC can be observed at least during the 150 
first trimester. In fact, studies have shown that NK cells begin to decrease in the blood 151 
circulation after 20-week gestation [42, 43]. NK cells were found to be important for immune 152 
response to influenza [44]. After 20-week gestation, levels of NK and T cells (particularly 153 
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CD4+ and CD8+) decrease from the second half of the pregnancy period [42]. Reduced levels 154 
of highly inflammatory Th1 cytokine release also occur during the later stages of pregnancy 155 
[43]. This dampening of the pro-inflammatory response, particularly NK cells, results in viral 156 
clearance delay of influenza infections, which leads to an increased risk of severe illness [43].  157 
In contrast, defensive immune responses (via phagocytic cells and α-defensins 1-3) were 158 
found to be elevated from the first trimester until at least 35-weeks gestation [42]. High 159 
levels of estrogen and progesterone also mediates these processes by suppressing pro-160 
inflammatory responses to infections and stimulating anti-inflammatory responses involved 161 
in defensive immunity [45]. Notably, the levels of these sex hormones surge from the first 162 
trimester and peak in the third [43]. Thus, the immune system is capable of preventing the 163 
establishment of viral infections as pregnancy progresses. But once the infection is 164 
established, the changes in the pulmonary physiology [40] and the reduced capacity to clear 165 
the infection [43] leads to increased risk of developing severe illness.  166 
The dampening of the pro-inflammatory responses in the later stages of pregnancy is 167 
evidently seen among pregnant women with auto-immune diseases like Rheumatoid 168 
Arthritis (RA), Multiple Sclerosis (MS) and Systemic Lupus Erythematosus (SLE). These auto-169 
immune diseases tend to have increased activity (or flares) during the early pregnancy stages, 170 
but decreased during the third trimester [46]. This tendency also correlates strongly with 171 
estrogen levels [43]. Notably, high levels of both sex hormones are associated with 172 
improvements to pulmonary function in pregnant asthmatic women [47].    173 
3.6. IMMUNE RESPONSES OF INFANTS UNDER 6 MONTHS 174 
Infants are thought be dependent on the innate immune system for protection against 175 
infections [48], whereby anti-inflammatory responses play a more dominant role. Directly 176 
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vaccinating infants under 6 months with the influenza vaccine is not allowed because their 177 
adaptive immune system is not mature enough to develop adequate immune response. 178 
Hence, one option to protect them against influenza is to acquire the influenza antibodies 179 
from the mother in utero. Infants who had acquired maternal antibodies against influenza 180 
[49, 50] and RSV [51] were reported to be protected from severe illness and had delayed 181 
symptom onset.   182 
3.7. MATERNAL VACCINATION FOR INFLUENZA AND RSV 183 
Maternal influenza vaccination is one of the safe and cost-effective ways of protecting both 184 
pregnant women as well as infants under 6 months [52, 53]. There is evidence that maternal 185 
influenza vaccination can induce a strong immune response to protect both mother and the 186 
unborn fetus. It was found to reduce influenza illness for both pregnant women [54-56] and 187 
infants under 6 months [25, 56, 57], and also reduce hospitalizations for infants under 6 188 
months [57-59]. In a randomized study in Bangladesh [56], maternal influenza vaccination 189 
reduced 63% of laboratory-confirmed influenza illness in infants under 6 months. It also 190 
reduced 29% and 36% of febrile respiratory illness in infants under 6 months and pregnant 191 
women, respectively. Another study found an association between maternal influenza 192 
vaccine use and reduced likelihood of premature and small for gestational age births [60]. 193 
No serious adverse effects have been reported for influenza vaccination during pregnancy 194 
[61], though there were limited information available on the safety of vaccination during the 195 
first trimester [62]. Also, vaccine effectiveness is similar between pregnant women and other 196 
adults [54]. The WHO Strategic Advisory Group of Experts (SAGE) on immunization 197 
recommended that pregnant women should be vaccinated against influenza at any 198 
pregnancy stage [3]. 199 
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RSV vaccines are currently not available for any age groups, but they are now under 200 
development for four targeted groups, two of which are the infants under 6 months and 201 
pregnant women [63]. However, vaccine development proves to be a challenge for each 202 
group. On one hand, there is a concern on how vaccine may respond among infants under 6 203 
months who have immature immune system and maternal antibodies. On the other hand, 204 
there is also a probable risk of adverse fetal outcomes for pregnant women who get 205 
vaccinated. Nonetheless, when it is made available and safety for both mother and fetus are 206 
assured, maternal RSV vaccination could be one useful strategy to prevent severe disease 207 
among infants under 6 months [64, 65]. Subunit vaccines are being considered for pregnant 208 
women and are currently on development [63]. Another good option is to vaccinate school-209 
age children as it was shown to be effective in both field [66] and modeling [67] studies.  210 
Currently, the only available preventive measure against RSV infection among infants under 211 
6 months is the monoclonal antibody, palivizumab [65]. However, it is expensive to 212 
administer, has to be administered monthly throughout the RSV season, and does not 213 
always prevent serious RSV disease [65, 68].  214 
3.8. RESEARCH GAPS AND STUDY SIGNIFICANCE 215 
One important research gap is that there is currently limited information on the burden of 216 
respiratory viruses for both pregnant women and infants under 6 months at the community 217 
level. As outlined above, it is known that pregnant women have high morbidity and mortality 218 
rates due to influenza and that the highest impact was observed during pandemics and also 219 
on those in the third trimester. However, this is based mainly on hospital data, which could 220 
be biased toward severe cases. To my knowledge, only two studies reported on ILI episodes 221 
at the clinic level for pregnant women [13, 17]. Thus, including data at the community level 222 
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would enable us to see the overall picture of the true disease burden.  A similar argument 223 
can also be made for infants under 6 months. Like pregnant women, high morbidity and 224 
mortality rates were also reported for both influenza and RSV but most population-based 225 
studies relied on hospital data. There were also quite few similar studies on infants under 6 226 
months for influenza infections (in Bangladesh [56] and United States [25]) and RSV 227 
infections (in Kenya [26]).   228 
For pregnant women, there are a lot of epidemiological reports of high risk to severe 229 
influenza-associated illness, but not for susceptibility to influenza infections. There is also 230 
few data on whether pregnant women would be more susceptible to infection at a particular 231 
trimester stage. Information on the infection risk of pregnant women in the first trimester is 232 
also lacking [62]. Thus, data collected from this study would allow us to investigate on any 233 
differences in the susceptibility risk between all three trimesters.  234 
In addition, the study results would also benefit Mongolia. There are a few reasons why 235 
Mongolia is chosen as the study site. First, maternal and child health is currently one of the 236 
important health issues in Mongolia due to its high birth rate and population growth. 237 
Between 2005 and 2014, the number of live births increased at an average rate of 6.4% [69, 238 
70]. In 2014, the estimated annual birth rate is 20.9 per 1,000 persons [71]. Second, it was 239 
previously shown that children < 5 years old in Mongolia have the highest incidence of 240 
influenza-associated illness [72]. Third, the burden among pregnant women has never been 241 
assessed in the country, even though 24.1% of all influenza A(H1N1)pdm09-confirmed 242 
deaths in Mongolia were pregnant [73]. During the study period, the country’s national 243 
influenza vaccination policy did not include pregnant women as one of the recommended 244 
vaccine recipients [74]. Therefore, the study findings can thus help inform on any disease 245 
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burden from influenza and/or RSV among these two growing population groups residing in 246 
semi-urban areas of Mongolia. 247 
4. STUDY OBJECTIVES 248 
The study objectives are to determine the incidence and risk factors of influenza-like illness 249 
(ILI), severe acute respiratory infection (sARI) and virus-positive cases (influenza A, influenza 250 
B and RSV infection) among pregnant women and infants under 6 months.   251 
 
 
15 
5. MATERIALS AND METHODS 252 
5.1. STUDY SITE 253 
Baganuur is a semi-urban district located at about 130 km away from the central part of 254 
Ulaanbaatar, Mongolia’s capital city (Fig. 1). In 2013, it had an estimated population of 255 
27,440. Medical services are provided mainly by one district hospital and four primary 256 
healthcare centers called Family General Practitioners (FGPs). The study was conducted in 257 
this district for two consecutive influenza seasons (October 1st 2013 - April 30th 2014 and 258 
October 1st 2014 - April 30th 2015). 259 
5.2. DATA COLLECTION 260 
In Mongolia, all pregnant women and children < 2 years old are required to register and 261 
undergo medical check-ups at their FGPs, which are assigned based on their official 262 
residential address. All four FGPs in the district were used as the study entry point. All 263 
residents who registered at the FGPs and met the inclusion criteria (being pregnant or aged 264 
< 24 weeks during the study period) were enrolled. To include those who had already 265 
registered and those newly registered during the study period, enrolment was carried out 266 
continuously throughout the whole study period. Follow-up ends if any of the following 267 
occurred: a woman was no longer pregnant, a child reached 24 weeks of age, or any 268 
participant moved away from Baganuur district. 269 
At the time of enrolment, a baseline questionnaire was administered to all participants to 270 
collect their demographic information. Prenatal information and household member 271 
demographics were also collected from pregnant women for both seasons. For infants under 272 
6 months, information on birthweight, gestational age at delivery and presence of birth 273 
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defects were collected for both seasons, while the household member demographics were 274 
collected only during the 2014/15 season. Household members who were < 18 years old 275 
were categorized as: young child (until 2 years), kindergarten-age (2 – 5 years), and school-276 
age (6 – 17 years).   277 
For pregnant women, an obstetrician in the district hospital on their first check-up carries 278 
out initial antenatal examination, and the results are recorded in the antenatal check-up 279 
record book. This book served as the major source of baseline data in this study. The 280 
obstetrician classifies all pregnant women as either normal or high risk to indicate whether 281 
she would undergo routine or extensive antenatal check-ups, respectively. The first day of 282 
the last menstruation was used to determine the start date of pregnancy and the trimester 283 
stages were defined as: first (0 - 13 weeks), second (14 - 26 weeks), and third (27 weeks and 284 
above). Baseline height and weight information were also collected to calculate the body 285 
mass index (BMI). Pregnant women were defined as with co-morbidity if she, at the time of 286 
the antenatal examination, has any of the following medical conditions that pre-disposes 287 
them to influenza-related complications [75]: pulmonary, cardiovascular, renal, and 288 
metabolic conditions.    289 
For infants under 6 months, low birthweight was defined as those born weighing < 2500g. 290 
Three categories were defined for term of pregnancy [76, 77]: preterm, early term, and full 291 
term.  292 
The primary outcome in this study was the occurrence of a case positive for either influenza 293 
A, influenza B or RSV. The secondary outcome was the occurrence of an ILI or a sARI case. An 294 
ILI case was defined as the sudden onset of fever of ≥38°C, or with history of fever, and 295 
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cough within the last 7 days. A sARI case was defined as having ILI symptoms and requires 296 
hospitalization.  297 
Throughout the study period, scheduled follow-up calls were carried out twice a week (one 298 
call every 2 - 5 days) to actively identify any ILI episodes among the study participants. When 299 
an ILI episode was identified, a timely home visit was made to interview him/her with a case 300 
report form and to collect a nasopharyngeal swab for on-site testing with a point-of-care test 301 
kit (QuickNaviTM – Flu + RSV, Denka Seiken Co. Ltd). This commercially available kit enables 302 
simultaneous detection of influenza A, influenza B and RSV. In the subsequent two follow-303 
ups calls, the resolution of ILI symptoms was also recorded. If the ILI case had recovered 304 
from symptoms on the day of follow-up call, that date was used as the date of symptom 305 
resolution. 306 
At the district hospital, information on sARI episodes (admission and discharge dates, 307 
symptoms presented, clinical indicators, diagnosis at discharge and outcome, and point-of-308 
care test results) was collected. There were some cases who initially visited the FGP for 309 
testing, then later referred for hospitalization. An episode whose interval between FGP visit 310 
and hospital admission is < 7 days was considered as the same illness episode. 311 
The district hospital and all four FGPs in Baganuur are also a part of the national ILI 312 
surveillance program in Mongolia. Nasopharyngeal swabs were collected randomly from ILI 313 
cases and routinely tested for influenza virus using real-time polymerase chain reaction 314 
(PCR). Some randomly selected samples were further tested for other respiratory viruses, 315 
including RSV. According to this surveillance [78], three influenza strains [A(H1N1)pdm09, 316 
A(H3N2), and B] were detected during the 2013/14 season, while A(H3N2) and RSV were 317 
detected during the 2014/15 season (Fig. 2). Some of the study participants (5.6%), who 318 
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missed testing by the study’s kits, were instead tested under this surveillance.  These results 319 
were also collected and combined into the analyses. 320 
All field staff involved had been trained with participant interviewing as well as sample 321 
collecting, testing and result interpretation. The field supervisor monitored all activity from 322 
data collection to encoding.  323 
5.3. ETHICAL APPROVAL 324 
Ethical approval for this study was obtained from the Ethics Committee of Tohoku University, 325 
Graduate School of Medicine, Sendai, Japan (2013-1-253), the Scientific Committee of 326 
National Center of Communicable Diseases, Mongolia (14/126), and the Ministry of Health, 327 
Mongolia (2014-02). Informed consent was obtained from eligible participants or their 328 
parents/guardians before study enrolment as well as from identified ILI and sARI cases 329 
before data and sample collection.  330 
5.4. STATISTICAL ANALYSIS 331 
Overall incidence rates (IR) were derived by dividing the actual number of cases detected 332 
with the total person-days at risk, and 95% confidence intervals (C.I) were calculated using 333 
exact methods. For participants with ILI or sARI, the symptomatic period was considered as 334 
days not-at-risk of infection and therefore not included in the denominator. For those with 335 
missing symptom resolution dates, I set 7 days as the duration of symptoms, based on 336 
previous studies on adults [79] and children < 1 year old [80]. For sARI cases, the 337 
symptomatic period was defined as the number of hospitalized days.  338 
I also investigated the risk factors of getting ILI, sARI and virus positive cases. Participants 339 
who did not have ILI symptoms (non-ILI group) were initially compared univariately with the 340 
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ILI cases and also with each virus positive cases. sARI cases were only investigated for infants 341 
under 6 months, and they were compared univariately with those who were not hospitalized 342 
for sARI (non-sARI group). Parametric (Student’s t and chi-square) and non-parametric 343 
(Wilcoxon rank sum and Fisher’s exact) tests were used whenever appropriate. Factors with 344 
a p-value of ≤ 0.1 and deemed relevant for acquiring illness episodes were then included in 345 
the Cox proportional hazards (PH) regression model. In all models runs, non-ILI or non-sARI 346 
were used as the comparison group. Participants with multiple episodes within each season 347 
were also accounted for, in both un-adjusted and adjusted models. To ensure that the model 348 
assumptions were met, diagnostic tests on the proportional hazards assumption were done 349 
and the residuals were also checked. For pregnant women, all covariates except age at 350 
enrolment were categorically included in the final Cox PH model. Alternative model runs 351 
using categorized age quartiles were consistent with the main results reported. For infants 352 
under 6 months, all covariates included were categorical. A p-value of < 0.05 was considered 353 
statistically significant.      354 
I hypothesize that trimester stage (for pregnant women) and age group (for infants under 6 355 
months) could contribute to differences in infection risk. Therefore, I also stratified the IR 356 
calculations accordingly and included them as the time-dependent variable in the Cox PH 357 
model. Microsoft Excel and R software, version 3.2.0 [81] were used for all analyses.  358 
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6. RESULTS 359 
6.1. DISTRIBUTION OF ILI AND SARI CASES, AND CIRCULATING VIRUSES IN BOTH POPULATIONS 360 
Figure 3 shows the weekly number of ILI and sARI cases in pregnant women and infants 361 
under 6 months during the study period. Most ILI and sARI cases tend to occur between 362 
November to March, coinciding with winter months in Mongolia. The temporal trend of sARI 363 
correlated with that of ILI in infants (r2 = 0.71) while there were only 2 sARI cases observed in 364 
pregnant women.  365 
Figure 4 shows the weekly number of virus positives detected in the two populations. In 366 
general, positive cases were detected mainly from January to February, coinciding with the 367 
high activities of both ILI and sARI. All three targeted viruses were detected during the 368 
2013/14 season, while influenza B virus was not detected during the 2014/15 season. This 369 
was quite consistent with data from the national ILI surveillance, except that RSV was not 370 
detected during the 2013/14 season (Fig. 2). There were periods of limited point-of-care test 371 
kit availability at the beginning of both seasons and early December in the 2014/15 season. 372 
Hence, virus testing was compromised during those periods.  373 
6.2. INCIDENCE RATES OF ILI, SARI AND VIRUS POSITIVES FOR PREGNANT WOMEN 374 
We individually enrolled 1,260 pregnant women and they were followed for a total of 375 
120,887 person-days. The population characteristics were quite different for the two 376 
seasons (Table 1). Briefly, the 2014/15 season cohort tend to be more educated, employed, 377 
overweight, enrolled at an earlier gestational age, and did not have co-morbidities. The 378 
median age at enrolment was 27 years (range: 16 – 44) and 43.0% were enrolled during the 379 
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first trimester. Among all pregnant women identified, only seven refused to join the study. 380 
None was lost to follow-up and none had received the influenza vaccine.  381 
A total of 174 ILI episodes (13.8%) were detected from 160 pregnant women. There were 12 382 
and 2 women with 2 and 3 ILI episodes respectively, during the same influenza season. 383 
Among the ILI cases with recorded symptom resolution dates (85.6%), the mean interval to 384 
resolution was 8.1 days (range: 3 - 20). The overall IR for ILI was 11.8 per 1,000 person-days 385 
(95% C.I: 11.2 – 12.4) (Table 2a).  386 
Among all tested ILI cases (n = 165), 26 (15.8%) tested positive for influenza A, 2 (1.2%) for 387 
influenza B, and 4 (2.4%) for RSV. This gives an overall IR of 1.7 per 1,000 person-days (95% 388 
C.I: 1.5 – 1.9) for influenza A, 0.1 per 1,000 person-days (95% C.I: 0.1 – 0.2) for influenza B, 389 
and 0.3 per 1,000 person-days (95% C.I: 0.2 – 0.4) for RSV (Table 2b). The majority of 390 
samples (96.0%) were tested within 5 days after symptom onset. During the 2014/15 season, 391 
2 women tested positive for both influenza A and RSV from separate ILI episodes.  392 
Two sARI cases were also detected, giving an overall sARI incidence rate of 0.1 per 1,000 393 
person-days (95% C.I: 0.04 – 0.4). One case tested negative in the 2014/15 season during her 394 
second trimester, and another was positive for influenza A during the 2013/14 season during 395 
her first trimester. No virus co-detection and deaths were observed during the study period.  396 
IRs for ILI and influenza A were the lowest in the third trimester (Table 2). Sensitivity analysis 397 
using total person-days only in January and February also revealed the same trend as the 398 
main result. This analysis was done because all influenza A positive cases were detected only 399 
in the latter months. Similar trend was also observed in the risk factor analysis for both ILI 400 
(Table 3a) and influenza A (Table 3b). When compared to the first trimester, pregnant 401 
women in the third trimester were 78% less likely to have influenza A detected, after 402 
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adjusting for age and presence of prior pregnancy [Adjusted hazard ratio (Adj. HR): 0.22 403 
(95% C.I: 0.07 – 0.73)]. Pregnant women were also 50% [Adj. HR: 0.50 (95% C.I: 0.34 – 0.75)] 404 
and 63% [Adj. HR: 0.37 (95% C.I: 0.25 – 0.55)] less likely to develop an ILI episode in the 405 
second and third trimesters, respectively, when compared to the first trimester. In addition, 406 
pregnant women who have any co-morbidity were 43% more likely to develop an ILI episode 407 
[Adj. HR: 1.43 (95% C.I: 1.06 – 1.94)]. 408 
6.3. ILI AND SARI INCIDENCE, AND VIRUS POSITIVITY RATES FOR INFANTS UNDER 6 MONTHS 409 
We individually enrolled 1,304 infants under 6 months and they were followed for a total of 410 
122,344 person-days. They were mainly healthy, whereby 88.4% were born full term, 2.9% 411 
had low birthweight, and 3.5% were born with a certain birth defect. Their baseline 412 
characteristics were similar for both seasons, except that there were significantly more full 413 
term infants in the 2014/15 season (Table 4). The median age at enrolment was 12 days 414 
(range: 0 – 167). During the 2013/14 season, 99.9% were breastfed for 6 months. Almost all 415 
identified infants participated in this study (99.0%) and none was lost to follow-up. 416 
A total of 246 ILI episodes (18.9%) were detected from 201 infants under 6 months. There 417 
were 37, 7 and 1 infants with 2, 3, and 4 ILI episodes, respectively, during the same influenza 418 
season. Among the ILI cases with recorded symptom resolution dates (82.2%), the mean 419 
interval to resolution was 7.5 days (range: 1 - 14). The overall ILI IR was 15.2 per 1,000 420 
person-days (95% C.I: 14.5 – 15.8) (Table 5a). From all tested ILI cases (n = 191), 15 (7.9%) 421 
influenza A, 3 (1.6%) influenza B and 8 (4.2%) RSV cases were detected. Most samples were 422 
tested within 5 days after symptom onset (98.8%). During the 2013/14 season, RSV was 423 
detected twice (on separate occasions) from one female infant of low birthweight and did 424 
not result in sARI hospitalization. 425 
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A total of 255 sARI hospitalized cases (19.6%) were detected from 218 infants under 6 426 
months, giving an overall sARI IR of 20.5 per 1,000 person-days (95% C.I: 19.7 – 21.3) (Table 427 
5a). There were 30 and 8 infants who were hospitalized for sARI twice and thrice, 428 
respectively, during the same influenza season. Also, 36 (14.1%) of them had prior visit to 429 
the FGP for the same illness episode. The mean length of hospital stay was 8.9 days (range: 0 430 
– 33). For all sARI cases, 74.3% were admitted within 5 days after symptom onset. A total of 431 
23 (18.3%) and 55 (42.6%) cases were tested during the 2013/14 and 2014/15 seasons, 432 
respectively. This gives an overall sARI testing rate of 30.6%. During the 2013/14 season, 4 433 
(17.4%) tested positive for RSV and 2 (8.7%) for influenza A while 13 (23.6%) RSV and no 434 
influenza A cases were detected during the 2014/15 season. No influenza B positive sARI 435 
cases were detected from either season. No virus co-detection and deaths were also 436 
observed during the study period. 437 
Overall, a total of 17 (6.3%) influenza A, 3 (1.1%) influenza B, and 25 (9.3%) RSV cases were 438 
detected among the tested ILI and sARI samples (n = 269) (Table 5b). Among the total 439 
positive cases detected, 2 (11.8%) influenza A and 17 (68.0%) RSV cases were detected 440 
among hospitalized cases with sARI. After stratification by age group, 16 – 24 weeks old 441 
infants had the highest ILI IR [26.8 per 1,000 person-days (95% C.I: 25.2 – 28.5)] and sARI IR 442 
[25.8 per 1,000 person-days (95% C.I: 24.2 – 27.4)] (Table 5a). The same trend was also 443 
observed in the positivity rates of influenza A and RSV (Table 5b). The increase in the RSV 444 
positivity rate started from the 8 – 15.9 weeks old group. Also, sARI cases were 1.4 times 445 
more likely to be male, when compared to non-sARI [Adj. HR: 1.40 (95% C.I: 1.07 – 1.83)] 446 
(Table 6).  447 
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7. DISCUSSION 448 
A cohort of unvaccinated pregnant women and infants under 6 months was prospectively 449 
followed to actively detect acute respiratory illnesses for two consecutive influenza seasons. 450 
With its high participation rate (about 99% for both populations) and no loss to follow up, 451 
this cohort arguably provides an accurate picture in Baganuur. Among pregnant women, I 452 
observed low overall IR for influenza A. Both ILI and influenza A IR were the lowest in the 453 
third trimester. There were also few sARI and influenza A positive hospitalized cases. Also, 454 
pregnant women with co-morbidity have about 1.4 times higher risk of developing an ILI 455 
episode. Among infants under 6 months, I observed moderately high ILI and sARI IRs. Older 456 
infants (16 – 24 weeks old) had higher ILI IR and positivity rates (of influenza A and RSV), 457 
while younger male infants (0 – 7.9 weeks old) had higher sARI IR. Among all influenza A and 458 
RSV positive infant cases, 11.8% and 68.0% were respectively identified among hospitalized 459 
cases with sARI.  460 
One study in the United States [13] reported both ILI and sARI IR for pregnant women in all 461 
three trimesters and they observed high IRs, especially for sARI. Both ILI and sARI IRs in the 462 
study are also higher than that previously reported for the reproductive-age population (15 463 
– 49 years) in Baganuur [82] and Mongolia [72], though it could possibly be due to active 464 
case search in the study. Expanding this study to include non-pregnant women of 465 
reproductive-age would allow us to see any impact of pregnancy in acquiring ILI and sARI. 466 
These Mongolian studies also reported incidence rates for young children, though 467 
aggregates of 0 – 11 months were used. Here, ILI IR in this study is higher than that reported 468 
in Baganuur [82]. Relatively high infant ILI IRs were also previously reported from Bangladesh 469 
[56] and the United States [25]. Nevertheless, caution should be taken for interpreting these 470 
 
 
25 
direct comparisons due to differences in case detection methods, study season, and health-471 
seeking tendencies, that is between women with and without pregnancy, as well as between 472 
younger and older infants. 473 
The same study from Mongolia [72] also reported influenza positive rates by age group. The 474 
overall influenza positive rates for both ILI and sARI cases were lowest in the 0 - 11 month 475 
age group and highest in the reproductive age groups (16 – 44 years). My study findings for 476 
infants under 6 months were consistent with the former, as more RSV positives than 477 
influenza were detected. The latter was also consistent with this study as pregnant women 478 
were mainly positive for influenza A. RSV infection was also documented for young working 479 
adults [20], though the attack rate was lower and symptom severity was milder than those 480 
of infants. Despite the fact that influenza B can affect people of all ages, only few influenza B 481 
cases were detected in both pregnant women and infants, presumably reflecting the 482 
circulation of influenza virus in the community.  483 
Both IR and adjusted HR of influenza A were lowest for pregnant women in the third 484 
trimester, which could be due to differences in virus exposure at each trimester stage. 485 
Studies in the United States have shown that women in the third trimester tend to engage in 486 
lesser leisure activities [83] and spend more time at home [84]. Although it is uncertain 487 
whether both tendencies are also observed among Mongolians, it can lead to less 488 
interaction with others in the community, thus decreasing the probability of acquiring 489 
respiratory infections. Notably, I also observed the same finding in the risk factor analysis for 490 
ILI, after accounting for the presence of co-morbidity as well as possible transmission in the 491 
household (presence of kindergarten-age child) and workplace (employment status). This 492 
suggests that settings other than household and workplace may contribute to a certain risk 493 
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of acquiring ILI and possibly influenza A infections. However, my finding contradicts with that 494 
in a previous study, which showed high IR of influenza A in the third trimester [17]. 495 
Experimental studies have reported that the immune system switch to defensive mode 496 
during pregnancy [42]. Defensive immune responses (via phagocytic cells and α-defensins 1-497 
3) are elevated throughout the pregnancy period [42]. Estrogen and progesterone levels, 498 
which surge from the first trimester [43], further strengthens this by stimulating anti-499 
inflammatory responses [45]. This means that the immune system is capable of preventing 500 
the establishment of viral infections as pregnancy progresses, and that there is little 501 
immunological basis for increasing susceptibility to influenza infection [38]. Hence, my study 502 
finding is in fact more consistent to what is known with the immunological changes during 503 
pregnancy. 504 
Low sARI IR among pregnant women was observed and only one was positive for influenza A. 505 
This observation is in line with some studies [15, 16], but there are also many reports of 506 
increased influenza-associated hospitalization rates during the inter-pandemic periods [10-507 
14, 18]. My study findings could firstly be due to the relatively mild influenza seasons. 508 
Antigenic changes to the circulating strains seemed limited during both seasons under study, 509 
as the WHO-recommended vaccine strains were the same [85]. Thus, the enrolled pregnant 510 
women may have already had the infection to a similar strain prior to the current pregnancy. 511 
Secondly, it could also be the low sample size of this study, which makes it difficult to detect 512 
severe illnesses that occur at a low rate.   513 
It was also observed that pregnant women with co-morbidity had 1.4 times higher risk of 514 
developing an ILI episode, a finding which is consistent with previous studies [13]. Although 515 
this HR estimate was for both seasons, additional analysis for each season revealed 516 
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significance only for the 2014/15 season (Table 9). When compared to the 2013/14 season, 517 
the 2014/15 season had a lower proportion of pregnant women with co-morbidity enrolled 518 
and influenza A activity was also higher. This thus suggests that having co-morbidity is in fact 519 
a risk factor of developing ILI symptoms associated with influenza among pregnant women. 520 
Of note, this finding needs to be interpreted with caution. In the antenatal care book, each 521 
comorbidity condition was broadly categorized to include a broad list of acute and chronic 522 
medical conditions listed under the International Classification of Diseases (ICD-10). We 523 
could not get further details on these conditions as they were recorded in another record 524 
book. Hence, it is likely that pregnant women whom I labeled as with co-morbidity include 525 
those with acute conditions.    526 
The striking demographic differences between the pregnant women population for both 527 
seasons is unexpected but unlikely due to any sampling or selection bias. This is because all 528 
identifiable pregnant women were enrolled into this study. Some women, who are Baganuur 529 
residents but work/study outside Baganuur, may choose to stay in the district during their 530 
pregnancy. This is probable because their assigned FGP for antenatal checkup was based on 531 
their residential address. This tendency could also vary between seasons.  532 
The ILI and sARI IR for infants under 6 months were the highest among the 16 – 24 weeks old 533 
group and similar trend was also observed in the positivity rates of both influenza A and RSV. 534 
In fact, 100% and 82.4% of the influenza A and RSV positive sARI cases, respectively, were 535 
found in those aged 8 weeks or older. Notably, this finding for RSV is consistent with that in 536 
Kenya [86]. This could be explained by the waning of passively acquired maternal antibodies. 537 
Infants under 6 months who had acquired maternal antibodies against influenza [49, 50] and 538 
RSV [51] were reported to be protected from severe illness and had delayed symptom onset. 539 
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Also, protection from maternal antibodies tends to wane after the first 2 - 3 months of life. 540 
Previous studies reported the half-life of passively-acquired maternal antibodies to be 21 – 541 
53 days against influenza [49, 50, 87, 88] and 26 – 78 days against RSV [89-91].  542 
sARI IR was also high among the 0 – 7.9 weeks old infants, giving the impression of low IR 543 
among the 8 – 15.9 weeks old. However, this could be falsely elevated due to two reasons. 544 
First, young infants tend to exhibit signs of breathing difficulties, regardless of infection 545 
severity. Thus, parents/guardians tend to bring them directly to the hospital for immediate 546 
care. In fact, only 38 sARI cases (14.8%) were referred to the hospital from the FGP; hence 547 
suggesting a small number of ‘true’ sARI cases. Second, Mongolia follows the integrated 548 
management of childhood illness (IMCI) guidelines, whereby infants < 2 months old with 549 
fever are to be directly admitted to the hospital as a sARI case [92]. Hence, the high 550 
tendency to seek healthcare at the hospital and the implementation of the IMCI guidelines 551 
could explain the high sARI IR among younger infants. This could also be one reason why the 552 
overall IR for sARI was higher than that of ILI.  553 
It was also observed that 68.0% of RSV-positives detected were hospitalized with sARI, which 554 
is highly disproportionate when compared to that of influenza A (11.8%). This tendency is 555 
consistent with previous studies on hospitalized infants in the United States [27, 28, 31] and 556 
Thailand [32]. This data indicates that RSV caused more severe illness that required 557 
hospitalization among infants under 6 months in Baganuur. As the testing rate was low, 558 
particularly for sARI cases, it means that the actual proportion of hospitalized cases for both 559 
viruses could be much higher.  560 
Infant sARI cases were 1.4 times more likely to be males, a trend that is consistent with 561 
previous reports [23] and also seen with RSV-associated hospitalizations [33]. When 562 
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compared to females, young male infants tend to have reduced airway function [34, 35] and 563 
also tend to be more susceptible to infection [36]. In addition, all the RSV positive sARI cases 564 
were born full term. This means that RSV disease can also affect healthy infants, a finding in 565 
line with previous studies [28, 30].   566 
Some study limitations need to be addressed. First, point-of-care test was the main 567 
diagnostic method used, which could lower the sensitivity of virus detection. A meta-analysis 568 
on influenza test kit evaluation studies reported a pooled sensitivity and specificity of 62.3% 569 
and 98.2%, respectively [93]. Thus, the incidence and positivity rates reported in this study 570 
are an underestimate, possibly by about 40%. For RSV, antigen detection methods are 571 
known to be considerably less sensitive particularly for adults [94]. Point-of-care test kits 572 
were used mainly due to the limited laboratory capacity to test samples with real-time PCR. 573 
It also allowed us to simultaneously test for RSV, as the local laboratory only tests routinely 574 
for influenza. In order to ensure higher viral loads in the samples taken, efforts were made 575 
to identify cases within 5 days of symptom onset, and to test them as soon as possible upon 576 
identification. Second, the overall testing rate was low, particularly for the infant sARI cases 577 
(30.6%). This remains to be a major limitation even though the sARI testing rate improved 578 
from 18.1% in the 2013/14 season to 42.6% in the 2014/15 season. Hence, the positive case 579 
numbers reported for the infants under 6 months are an underestimate. While one major 580 
reason for the low testing rate was the limited test kits supply during some study periods, 581 
there were also a certain percentage of infants whose sampling was refused by their 582 
parents/guardians. Unfortunately, we did not collect detailed data for this. Third, as a 583 
consequence of using point-of-care test kits, I also could not provide the IR by influenza 584 
subtype and RSV genotype. Fourth, we did not assess the use of non-pharmaceutical 585 
interventions, such as hand washing and facemask usage, in our study population. This could 586 
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possibly affect the risk factor analysis results. Fifth, I did not detect enough virus-positive 587 
cases from both seasons to assess their risk factors. This could merely reflect the low 588 
influenza and RSV activities in this community and thus caution must be taken to extrapolate 589 
these findings to other areas in Mongolia. Sixth, dates of follow-up and hospitalization were 590 
used to determine the symptomatic period for ILI and sARI IR calculations, respectively. 591 
These dates do not strictly reflect on each clinical course and may affect the calculated IRs. 592 
Lastly, household demographic information was collected among infants only for the 593 
2014/15 season. As a result, these data were excluded from the risk factor analyses for both 594 
seasons.   595 
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8. CONCLUSION 596 
I reported the results of a prospective, observational open cohort study conducted in a 597 
community setting for two targeted high-risk groups, during two consecutive influenza 598 
seasons in Mongolia. I observed a low overall influenza A burden for pregnant women in 599 
terms of incidence and hospitalization rates, though underestimation was likely due to point-600 
of-care tests used. One surprising finding is the low influenza A incidence rate among the 601 
third trimester women, despite their particularly high risk of developing influenza-related 602 
severe illness. While for infants under 6 months, the incidence of ILI and sARI was 603 
moderately high. An important note here is the high number of RSV positives who got 604 
hospitalized when compared to that of influenza A, despite the low testing rate. Including 605 
additional data from subsequent influenza seasons would help to ascertain these findings. 606 
Despite its limitations, my study findings add into the currently limited knowledge on the 607 
burden of seasonal influenza for both groups. This is also the first study of its kind in 608 
Mongolia, a developing country where maternal and child health is an important health 609 
topic.   610 
 
 
32 
9. REFERENCES  611 
1. Kawaoka Y, editor. Influenza Virology: Current Topics: Caister Academic Press; 2006. 612 
2. Frank AL, Taber LH, Glezen WP, et al. Influenza B virus infections in the community 613 
and the family: The epidemics of 1976–1977 and 1979–1980 in Houston, Texas. Am J 614 
Epidemiol. 1983;118(3):313-25. 615 
3. WHO position paper on influenza vaccines - November 2012. Wkly Epidemiol Rec. 616 
2012;87:461-76. 617 
4. Borchers A, Chang C, Gershwin M, et al. Respiratory Syncytial Virus-A Comprehensive 618 
Review. Clin Rev Allergy Immunol. 2013;45(3):331-79. 619 
5. Groothuis J, Hoopes JM, Jessie VH. Prevention of serious respiratory syncytial virus-620 
related illness. I: Disease pathogenesis and early attempts at prevention. Adv Ther. 621 
2011;28(2):91-109. 622 
6. Harris JW. Influenza occurring in pregnant women: A statistical study of thirteen 623 
hundred and fifty cases. JAMA. 1919;72(14):978-80. 624 
7. Freeman DW. Deaths from Asian influenza associated with pregnancy. Am J Obstet 625 
Gynecol. 1959;78(6):1172-5. 626 
8. Van Kerkhove MD, Vandemaele KAH, Shinde V, et al. Risk Factors for Severe 627 
Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med. 628 
2011;8(7):e1001053. 629 
9. Mosby LG, Rasmussen SA, Jamieson DJ. 2009 Pandemic Influenza A (H1N1) in 630 
Pregnancy: A systematic review of the literature. Am J Obstet Gynecol. 2011;205(1):10-8. 631 
10. Cox S, Posner S, McPheeters M, et al. Hospitalizations with respiratory illness among 632 
pregnant women during influenza season. Obstet Gynecol. 2006;107(6):1315-22. 633 
11. Schanzer DL, Langley JM, Tam TW. Influenza-Attributed Hospitalization Rates Among 634 
Pregnant Women in Canada 1994–2000. J Obstet Gynaecol Can. 2007;29(8):622-9  635 
12. Hartert TV, Neuzil KM, Shintani AK, et al. Maternal morbidity and perinatal outcomes 636 
among pregnant women with respiratory hospitalizations during influenza season. Am J 637 
Obstet Gynecol. 2003;189(6):1705-12. 638 
13. Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital 639 
admissions and physician visits because of respiratory illness among pregnant women. Can 640 
Med Assoc J. 2007;176(4):463-8. 641 
14. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of Influenza on Acute 642 
Cardiopulmonary Hospitalizations in Pregnant Women. Am J Epidemiol. 1998;148(11):1094-643 
102. 644 
15. Mullooly JP, Barker WH, Nolan TF. Risk of acute respiratory-disease among pregnant-645 
women during influenza-A epidemics. Public Health Rep. 1986;101(2):205-11. 646 
16. Black SB, Shinefield HR, France EK, et al. Effectiveness of Influenza Vaccine during 647 
Pregnancy in Preventing Hospitalizations and Outpatient Visits for Respiratory Illness in 648 
Pregnant Women and Their Infants. Amer J Perinatol. 2004;21(06):333-9. 649 
17. Lindsay L, Jackson LA, Savitz DA, et al. Community Influenza Activity and Risk of Acute 650 
Influenza-like Illness Episodes among Healthy Unvaccinated Pregnant and Postpartum 651 
Women. Am J Epidemiol. 2006;163(9):838-48. 652 
18. Martin A, Cox S, Jamieson D, et al. Respiratory Illness Hospitalizations Among 653 
Pregnant Women During Influenza Season, 1998–2008. Matern Child Health J. 654 
2013;17(7):1325-31. 655 
 
 
33 
19. McNeil SA, Dodds LA, Fell DB, et al. Effect of respiratory hospitalization during 656 
pregnancy on infant outcomes. Am J Obstet Gynecol. 2011;204(6, Supplement):S54-S7. 657 
20. Hall CB, Long CE, Schnabel KC. Respiratory Syncytial Virus Infections in Previously 658 
Healthy Working Adults. Clin Infect Dis. 2001;33(6):792-6. 659 
21. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to 660 
seasonal influenza in young children: a systematic review and meta-analysis. The Lancet. 661 
2011;378(9807):1917-30. 662 
22. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory 663 
infections due to respiratory syncytial virus in young children: a systematic review and meta-664 
analysis. The Lancet. 2010;375(9725):1545-55. 665 
23. Nair H, Simões EAF, Rudan I, et al. Global and regional burden of hospital admissions 666 
for severe acute lower respiratory infections in young children in 2010: a systematic analysis. 667 
The Lancet. 2013;381(9875):1380-90. 668 
24. Henkle E, Steinhoff M, Omer S, et al. Incidence of influenza virus infection in early 669 
infancy: a prospective study in South Asia. Pediatr Infect Dis J. 2011;30(2):170-3. 670 
25. Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on 671 
influenza virus infection in young infants. Arch Pediatr Adolesc Med. 2011;165(2):104-11. 672 
26. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory Syncytial Virus Infection and Disease 673 
in Infants and Young Children Observed from Birth in Kilifi District, Kenya. Clin Infect Dis. 674 
2008;46(1):50-7. 675 
27. Poehling KA, Edwards KM, Weinberg GA, et al. The Underrecognized Burden of 676 
Influenza in Young Children. N Engl J Med. 2006;355(1):31-40. 677 
28. Hall CB, Weinberg GA, Iwane MK, et al. The Burden of Respiratory Syncytial Virus 678 
Infection in Young Children. N Engl J Med. 2009;360(6):588-98. 679 
29. Izurieta H, Thompson W, Kramarz P, et al. Influenza and the rates of hospitalization 680 
for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-9. 681 
30. Nolan T, Borja-Tabora C, Lopez P, et al. Prevalence and Incidence of Respiratory 682 
Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years 683 
With Influenza-like Illness Enrolled in a Randomized Trial. Clin Infect Dis. 2015;60(11):e80-e9. 684 
31. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-Based Surveillance for 685 
Hospitalizations Associated With Respiratory Syncytial Virus, Influenza Virus, and 686 
Parainfluenza Viruses Among Young Children. Pediatrics. 2004;113(6):1758-64. 687 
32. Hasan R, Rhodes J, Thamthitiwat S, et al. Incidence and Etiology of Acute Lower 688 
Respiratory Tract Infections in Hospitalized Children Younger Than 5 Years in Rural Thailand. 689 
Pediatr Infect Dis J. 2014;33(2):E45-E52. 690 
33. Simoes EAF. Environmental and demographic risk factors for respiratory syncytial 691 
virus lower respiratory tract disease. J Pediatr. 2003;143(5, Supplement):118-26. 692 
34. Jones M, Castile R, Davis S, et al. Forced Expiratory Flows and Volumes in Infants. Am 693 
J Respir Crit Care Med. 2000;161(2):353-9. 694 
35. Hoo AF, Dezateux C, Hanrahan J, et al. Sex-Specific Prediction Equations for V˙maxFRC 695 
in Infancy. Am J Respir Crit Care Med. 2002;165(8):1084-92. 696 
36. Klein SL. The effects of hormones on sex differences in infection: from genes to 697 
behavior. Neurosci Biobehav Rev. 2000;24(6):627-38. 698 
37. Friedrich L, Stein RT, Pitrez PMC, et al. Reduced Lung Function in Healthy Preterm 699 
Infants in the First Months of Life. Am J Respir Crit Care Med. 2006;173(4):442-7. 700 
38. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and Infection. N Engl J Med. 701 
2014;370(23):2211-8. 702 
 
 
34 
39. Gabriel G, Arck PC. Sex, Immunity and Influenza. J Infect Dis. 2014;209(suppl 3):S93-9. 703 
40. Sheffield J, Cunningham F. Community-Acquired Pneumonia in Pregnancy. Obstet 704 
Gynecol. 2009;114(4):915-22. 705 
41. Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. Am J 706 
Reprod Immunol. 2010;63(6):425-33. 707 
42. Kraus T, Engel S, Sperling R, et al. Characterizing the Pregnancy Immune Phenotype: 708 
Results of the Viral Immunity and Pregnancy (VIP) Study. J Clin Immunol. 2012;32(2):300-11. 709 
43. Pazos M, Sperling R, Moran T, et al. The influence of pregnancy on systemic immunity. 710 
Immunol Res. 2012;54(1-3):254-61. 711 
44. Jost S, Quillay H, Reardon J, et al. Changes in Cytokine Levels and NK Cell Activation 712 
Associated with Influenza. PLoS One. 2011;6(9):e25060. 713 
45. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune 714 
responses and disease pathogenesis. Horm Behav. 2012;62(3):263-71. 715 
46. Straub RH. The Complex Role of Estrogens in Inflammation. Endocr Rev. 716 
2007;28(5):521-74. 717 
47. Haggerty CL, Ness RB, Kelsey S, et al. The impact of estrogen and progesterone on 718 
asthma. 2003;90(3):284-91. 719 
48. PrabhuDas M, Adkins B, Gans H, et al. Challenges in infant immunity: implications for 720 
responses to infection and vaccines. 2011;12(3):189-94. 721 
49. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza 722 
illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis 723 
J. 1987;6(4):398-403. 724 
50. Puck J, Glezen W, Frank A, et al. Protection of Infants from Infection with Influenza A 725 
virua by Transplacentally Acquired Antibody. J Infect Dis. 1980;142(6):844-9. 726 
51. Eick A, Karron R, Shaw J, et al. The role of neutralizing antibodies in protection of 727 
American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J. 728 
2008;27(3):207-12. 729 
52. Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and 730 
infants. Am J Obstet Gynecol. 2012;207(3, Supplement):S3-S8. 731 
53. Steinhoff MC, MacDonald N, Pfeifer D, et al. Influenza vaccine in pregnancy: policy 732 
and research strategies. The Lancet. 2014;383(9929):1611-3. 733 
54. Thompson MG, Li D-K, Shifflett P, et al. Effectiveness of Seasonal Trivalent Influenza 734 
Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based 735 
Case-Control Study During the 2010–2011 and 2011–2012 Influenza Seasons. Clin Infect Dis. 736 
2014;58(4):449-57. 737 
55. Madhi SA, Cutland CL, Kuwanda L, et al. Influenza Vaccination of Pregnant Women 738 
and Protection of Their Infants. N Engl J Med. 2014;371(10):918-31. 739 
56. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of Maternal Influenza Immunization in 740 
Mothers and Infants. N Engl J Med. 2008;359(15):1555-64. 741 
57. Dabrera G, Zhao H, Andrews N, et al. Effectiveness of seasonal influenza vaccination 742 
during pregnancy in preventing influenza infection in infants, England, 2013/14. 743 
Eurosurveillance. 2014;19(45):2-5. 744 
58. Benowitz I, Esposito DB, Gracey KD, et al. Influenza Vaccine Given to Pregnant 745 
Women Reduces Hospitalization Due to Influenza in Their Infants. Clin Infect Dis. 746 
2010;51(12):1355-61. 747 
59. Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on 748 
influenza hospitalizations in infants. Am J Obstet Gynecol. 2011;204(6, Supplement):S141-S8. 749 
 
 
35 
60. Omer SB, Goodman D, Steinhoff MC, et al. Maternal Influenza Immunization and 750 
Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective 751 
Cohort Study. PLoS Med. 2011;8(5):e1000441. 752 
61. Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol. 753 
2012;207(3, Supplement):S33-S7. 754 
62. Mak TK, Mangtani P, Leese J, et al. Influenza vaccination in pregnancy: current 755 
evidence and selected national policies. The Lancet Infectious Diseases. 2008;8(1):44-52. 756 
63. Anderson LJ, Dormitzer PR, Nokes DJ, et al. Strategic priorities for respiratory 757 
syncytial virus (RSV) vaccine development. Vaccine. 2013;31, Supplement 2 (Decade of 758 
Vaccines):B209-B15. 759 
64. Chu HY, Englund JA. Maternal Immunization. Clin Infect Dis. 2014;59(4):560-8. 760 
65. Meng J, Stobart CC, Hotard AL, et al. An Overview of Respiratory Syncytial Virus. PLoS 761 
Pathog. 2014;10(4):e1004016. 762 
66. Munywoki PK, Koech DC, Agoti CN, et al. The Source of Respiratory Syncytial Virus 763 
Infection In Infants: A Household Cohort Study In Rural Kenya. J Infect Dis. 764 
2014;209(11):1685-92. 765 
67. Poletti P, Merler S, Ajelli M, et al. Evaluating vaccination strategies for reducing infant 766 
respiratory syncytial virus infection in low-income settings. BMC Med. 2015;13. 767 
68. Groothuis J, Hoopes JM, Hemming V. Prevention of serious respiratory syncytial 768 
virus-related illness. II: Immunoprophylaxis. Adv Ther. 2011;28(2):110-25. 769 
69. Social and economic situation of Mongolia (As of the preliminary result of 770 
2013) National Statistical Office of Mongolia; 2014 [cited 2014 May 20]. Available from: 771 
http://en.nso.mn/uploads/users/6/files/web201401en.pdf. 772 
70. Social and economic situation of Mongolia (As of the preliminary result of 773 
2014) National Statistical Office of Mongolia; 2015 [cited 2015 May 15]. Available from: 774 
http://en.nso.mn/content/127. 775 
71. Central Intelligence Agency (CIA). The World Factbook: Mongolia  [cited 2014 Nov 18]. 776 
Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/mg.html. 777 
72. Burmaa A, Kamigaki T, Darmaa B, et al. Epidemiology and impact of influenza in 778 
Mongolia, 2007-2012. Influenza Other Respi Viruses. 2014;8(5):530-7. 779 
73. Baigalmaa J, Tuul T, Darmaa B, et al. Analysis of fatal outcomes from influenza 780 
A(H1N1)pdm09 in Mongolia. Western Pac Surveill Response J. 2012;3(3):43–8. 781 
74. Dwyer D, Barr I, Hurt A, et al. Seasonal influenza vaccine policies, recommendations 782 
and use in the World Health Organization's Western Pacific Region. Western Pac Surveill 783 
Response J. 2013;4(3):51-9. 784 
75. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza. 785 
Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 786 
Recomm Rep. 2005;54(RR-8):1-40. 787 
76. Spong CY. Defining “term” pregnancy: Recommendations from the defining “term” 788 
pregnancy workgroup. JAMA. 2013;309(23):2445-6. 789 
77. American College of Obstetricians and Gynecologists. Definition of term pregnancy. 790 
Committee Opinion No. 579.: Obstet Gynecol; 2013. p. 1139-40. 791 
78. Ministry of Health Mongolia, National Centre of Communicable Diseases, National 792 
Influenza Centre 2014 [cited 2014 May 9]. Available from: http://flu.mn/eng/. 793 
79. Macfarlane JT, Macfarlane RM, Rose DH, et al. Prospective study of aetiology and 794 
outcome of adult lower-respiratory-tract infections in the community. The Lancet. 795 
1993;341(8844):511-4. 796 
 
 
36 
80. Jedrychowski W, Galas A, Pac A, et al. Prenatal Ambient Air Exposure to Polycyclic 797 
Aromatic Hydrocarbons and the Occurrence of Respiratory Symptoms over the First Year of 798 
Life. Eur J Epidemiol. 2005;20(9):775-82. 799 
81. R Core Team. R: A language and environment for statistical computing. R Foundation 800 
for Statistical Computing, Vienna, Austria 2014. Available from: http://www.R-project.org/. 801 
82. Nukiwa N, Burmaa A, Kamigaki T, et al. Evaluating influenza disease burden during 802 
the 2008-2009 and 2009-2010 influenza seasons in Mongolia. Western Pac Surveill Response 803 
J. 2011;1(1):16-22. 804 
83. Evenson KR, Wen F. National trends in self-reported physical activity and sedentary 805 
behaviors among pregnant women: NHANES 1999–2006. Prev Med. 2010;50(3):123-8. 806 
84. Nethery E, Brauer M, Janssen P. Time-activity patterns of pregnant women and 807 
changes during the course of pregnancy. J Expo Sci Environ Epidemiol. 2008;19(3):317-24. 808 
85. World Health Organization. WHO recommendations on the composition of influenza 809 
virus vaccines 2015 [cited 2015 September 8]. Available from: 810 
http://www.who.int/influenza/vaccines/virus/recommendations/en/. 811 
86. Sande CJ, Cane PA, Nokes DJ. The association between age and the development of 812 
respiratory syncytial virus neutralising antibody responses following natural infection in 813 
infants. Vaccine. 2014;32(37):4726-9. 814 
87. Steinhoff MC, Omer SB, Roy E, et al. Influenza Immunization in Pregnancy — 815 
Antibody Responses in Mothers and Infants. N Engl J Med. 2010;362(17):1644-6. 816 
88. Englund JA, Mbawuike IN, Hammill H, et al. Maternal immunization with influenza or 817 
tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 818 
1993;168(3):647-56. 819 
89. Brandenburg AH, Groen J, Steensel-Moll HAv, et al. Respiratory syncytial virus specific 820 
serum antibodies in infants under six months of age: Limited serological response upon 821 
infection. J Med Virol. 1997;52(1):97-104. 822 
90. Chu HY, Steinhoff MC, Magaret A, et al. Respiratory Syncytial Virus Transplacental 823 
Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh. J Infect Dis. 824 
2014;210(10):1582-9. 825 
91. Ochola R, Sande C, Fegan G, et al. The Level and Duration of RSV-Specific Maternal 826 
IgG in Infants in Kilifi Kenya. PLoS One. 2009;4(12):e8088. 827 
92. Model IMCI handbook: Integrated management of childhood illness: World Health 828 
Organisation; 2005. Available from: 829 
http://www.who.int/maternal_child_adolescent/documents/9241546441/en/. 830 
93. Chartrand C, Leeflang MMG, Minion J, et al. Accuracy of Rapid Influenza Diagnostic 831 
Tests: A Meta-analysis. Ann Intern Med. 2012;156(7):500-11. 832 
94. Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 833 
2000;13(3):371-84. 834 
 835 
  836 
 
 
37 
10. ACKNOWLEDGEMENTS 837 
For this study, I would like to express their gratitude to the following for their valuable 838 
support: All personnel involved in the primary healthcare clinics and district hospital in 839 
Baganuur; personnel in National Influenza Center (NIC) and National Center for 840 
Communicable Diseases (NCCD) in Ulaanbaatar, Mongolia; Denka Seiken Co. Ltd, Japan who 841 
kindly donated rapid test kits in the 2014/15 season; and Dr. Mayuko Saito for her useful 842 
advice on the risk factor analyses. I really appreciated all the field members in Baganuur for 843 
their hard work in collecting such good quality data, and also for the warm welcome 844 
whenever we go to Baganuur for field supervision.   845 
Personally, I would like to thank the MEXT Monbukagakusho scholarship program for 846 
financially supporting my 7 years of graduate study in Japan (research student + Masters + 847 
PhD). Through this program, I have made many close friendships; enjoyed learning and 848 
practicing Japanese with the local people, and traveled to many parts of Japan. I’m also very 849 
grateful to the Department of Virology for a very fulfilling learning experience during these 7 850 
years, the chance to go to field trips in both the Philippines and Mongolia, and in shaping me 851 
to become better at infectious disease epidemiology and data analysis. My special thanks to 852 
Professor Hitoshi Oshitani and Assistant Professor Taro Kamigaki for their supervision and 853 
their willingness to tolerate any mistakes I may have made.   854 
 
 
38 
11. FIGURES 855 
 856 
Fig 1. Location of the study site, Baganuur (バガヌール地区 )  857 
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 858 
Fig 2. The weekly number of positive cases detected in Baganuur district for 2013/14 (left) 859 
and 2014/15 (right) seasons, based on the national ILI surveillance [78]. The bars show the 860 
number of positive cases for influenza A(H3N2) [brown], influenza A(H1N1)pdm09 [pink], 861 
influenza B [blue] and RSV [green]. Three influenza strains were detected during the 2013/14 862 
season, while influenza A(H3N2) and RSV were detected during the 2014/15 season.   863 
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 864 
Fig 3. The weekly number of influenza-like illness (ILI) [orange] and severe acute respiratory 865 
infections (sARI) [purple] cases during the 2013/14 (left) and 2014/15 (right) seasons, for 866 
pregnant women (a) and infants under 6 months (b). The black lines indicate periods of 867 
limited point-of-care test kit supply, thus testing was compromised in those weeks.    868 
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 869 
Fig 4. The weekly number of virus positives detected from ILI and sARI cases during the 870 
2013/14 (left) and 2014/15 (right) seasons, for pregnant women (a) and infants under 6 871 
months (b). The bars show the number of positive cases for influenza A (red), influenza B 872 
(blue) and RSV (green). The black lines indicate periods of limited point-of-care test kit 873 
supply, thus testing was compromised in those weeks. The overall testing rate for ILI and 874 
sARI cases are 94.8% and 100%, respectively, for pregnant women and 77.6% and 30.6%, 875 
respectively, for infants under 6 months.  876 
  877 
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12. TABLES 878 
Table 1. Baseline characteristics of the pregnant women cohort and its comparison between 879 
two seasons. 880 
Population characteristic 
Total 
cohort (%) 
2013/14 
season (%) 
2014/15 
season (%) 
p-value 
No. of pregnant women enrolled 1260 643 (51.0) 617 (49.0) 
 
Age at enrolment 
(years) 
Median ± sd 27.4 ± 6.1 27.0 ± 6.1 28.0 ± 6.0 0.07 
Range 16 - 44 16 - 43 16 - 44 
 
Educated at high-school level or lower 278 (22.1) 212 (33.0) 66 (10.7) <0.001* 
Employment 
status 
Employed 
#
 825 (65.5) 381 (59.3) 444 (72.0) 
 
Unemployed 326 (25.9) 193 (30.0) 133 (21.5) <0.001* 
Student 109 (8.6) 69 (10.7) 40 (6.5) 
 
BMI category ^ 
Underweight (< 18.5) 51 (4.1) 22 (3.4) 29 (4.7) 
 
Normal (18.5-24.9) 845 (67.1) 471 (73.4) 374 (60.6) 
 
Overweight (25-29.9) 296 (23.5) 126 (19.6) 170 (27.6) <0.001* 
Obese (≥ 30) 67 (5.3) 23 (3.6) 44 (7.1) 
 
Household characteristics  
   
Type of 
household 
structure ^ 
Apartment 544 (43.2) 297 (46.3) 247 (40.1) 
 
Ger 549 (43.6) 236 (36.7) 313 (50.7) <0.001* 
Private house 166 (13.2) 109 (17.0) 57 (9.2) 
 
Household size 
1 - 2 173 (13.7) 82 (12.8) 91 (14.7) 
 
3 - 4 693 (55.0) 353 (54.9) 340 (55.1) 0.5 
5 and above 394 (31.3) 208 (32.3) 186 (30.2) 
 
Young child present (< 2yrs) 135 (10.7) 61 (9.5) 74 (12.0) 0.18 
Kindergarten-age child present (2 - 5yrs) 491 (39.0) 244 (37.9) 247 (40.0) 0.48 
School-age child present (6 - 17yrs) 638 (50.6) 325 (50.5) 313 (50.7) 0.99 
Obstetrics characteristics  
   
FGP consulted 
A 296 (23.5) 159 (24.7) 137 (22.2) 
 
B 309 (24.5) 157 (24.4) 152 (24.6) 
 
C 404 (32.1) 195 (30.3) 209 (33.9) 0.51 
D 251 (19.9) 132 (20.6) 119 (19.3) 
 
Gestational age 
at enrolment 
Median ± sd 16.1 ± 9.6 19.4 ± 10.0 13.0 ± 8.4 <0.001* 
Range 1.7 - 41.0 1.7 - 41 2.6 - 38.7 
 
Has prior pregnancy 879 (69.8) 435 (67.7) 444 (72.0) 0.11 
Has any co-morbidity ^^ 440 (34.9) 323 (50.2) 117 (19.0) <0.001* 
Classified as high risk pregnancy 601 (47.7) 264 (41.1) 337 (54.6) <0.001* 
#
 Includes employment in power stations, coal mining, agriculture, offices, schools and healthcare  
^ Missing value for one participant 
^^ Missing value for two participants 
* p-value of < 0.05 is considered to be significant 
  881 
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Table 2. Incidence rates (IRs) of (a) ILI and sARI, and (b) influenza A, influenza B and RSV 882 
detected for pregnant women, stratified by trimester stage and for the overall cohort.  883 
(a) 884 
 885 
Trimester 
stage 
ILI sARI 
No. of 
cases 
IR per 1,000 person-
days (95% CI) 
No. of 
cases 
IR per 1,000 person-
days (95% CI) 
1st 35 29.0 (25.9 – 32.5) 1 0.9 (0.2 - 5.2) 
2nd 83 11.7 (10.9 – 12.6) 1 0.1 (0.03 - 0.8) 
3rd 56 8.70 (7.96 – 9.51) 0 0 (0.0 - 0.4) 
Overall 174 11.8 (11.2 - 12.4) 2 0.1 (0.04 - 0.4) 
 886 
(b) 887 
  888 
Trimester 
stage 
Influenza A Influenza B RSV 
No. of 
cases 
IR per 1,000 
person-days 
(95% CI) 
No. of 
cases 
IR per 1,000 
person-days 
(95% CI) 
No. of 
cases 
IR per 1,000 
person-days 
(95% CI) 
1st 6 4.4 (3.3 – 5.9) 1 0.9 (0.5 – 1.6) 1 0.8 (0.4 – 1.5) 
2nd 15 2.1 (1.7 – 2.5) 0 0  1 0.1 (0.1 – 0.3) 
3rd 5 0.7 (0.5 – 1.0) 1 0.1 (0.1 - 0.3) 2 0.3 (0.2 - 0.5) 
Overall 26 1.7 (1.5 – 1.9) 2 0.1 (0.1 - 0.2) 4 0.3 (0.2 - 0.4) 
  889 
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Table 3. Risk factor analysis results when comparing (a) ILI cases and non-ILI, and (b) 890 
influenza A positive cases and non-ILI among pregnant women. Covariates were chosen 891 
based on initial univariate analyses (Table 7). Estimates in bold indicate statistically 892 
significant covariates.  893 
(a) 894 
Pregnant women and ILI episodes 
Hazard ratio (95% C.I) 
Un-adjusted Adjusted 
Trimester of symptom 
onset 
1st 1 (ref) 1 (ref) 
2nd 0.52 (0.35 - 0.78) 0.50 (0.34 - 0.75) 
3rd 0.38 (0.25 - 0.56) 0.37 (0.25 - 0.55) 
Highest education 
attained 
College or higher 1 (ref) 1 (ref) 
High school or lower 0.69 (0.45 - 1.04) 0.92 (0.54 - 1.56) 
Employment status 
Employed # 1 (ref) 1 (ref) 
Unemployed 0.86 (0.59 - 1.26) 1.00 (0.67 - 1.50) 
Student 0.54 (0.27 - 1.08) 0.75 (0.31 - 1.81) 
FGP 
A 1 (ref) 1 (ref) 
B 1.46 (0.94 - 2.26) 1.44 (0.91 - 2.28) 
C 1.34 (0.87 - 2.06) 1.30 (0.85 – 1.99) 
D 1.06 (0.65 - 1.74) 1.13 (0.69 - 1.83) 
Age at enrolment 1.02 (1.00 – 1.05) 1.00 (0.97 – 1.03) 
Has any co-morbidity ^^ 1.41 (1.04 – 1.91) 1.43 (1.06 – 1.94) 
Classified as high risk pregnancy 1.28 (0.94 – 1.73) 1.15 (0.76 – 1.80) 
Has prior pregnancy 1.32 (0.92 - 1.89) 1.17 (0.76 - 1.80) 
Has kindergarten-age child (2 - 5yrs) in 
household 
1.19 (0.88 - 1.60) 1.11 (0.81 - 1.51) 
#
 Includes employment in power stations, coal mining, agriculture, offices, schools and healthcare  
^^ Missing value for two participants 
 895 
(b) 896 
Pregnant women and 
influenza A cases 
Hazard ratio (95% C.I) 
Un-adjusted Adjusted 
Trimester of symptom 
onset 
1st 1 (ref) 1 (ref) 
2nd 0.62 (0.24 - 1.59) 0.63 (0.24 - 1.62) 
3rd 0.22 (0.07 - 0.72) 0.22 (0.07 - 0.73) 
Age at enrolment 1.02 (0.96 - 1.09) 0.98 (0.90 - 1.07) 
Has prior pregnancy 3.09 (0.93 - 10.3) 3.45 (0.94 - 12.70) 
  897 
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Table 4. Baseline characteristics of the infants under 6 months cohort and its comparison 898 
between two seasons. 899 
Population characteristics 
Total cohort 
(%) 
2013/14 
season (%) 
2014/15 
season (%) 
p-value 
No. of infants  < 6 months enrolled 1304 692 (53.0) 612 (47.0) 
 
Male gender 673 (51.6) 364 (52.6) 309 (50.5) 0.48 
Age at enrolment 
(days) 
Median ± sd 12.0 ± 50.9 13.0 ± 51.7 9.0 ± 49.9 0.06 
Range 0 - 167 0 - 167 0 - 167 
 
Newborn characteristics  
   
Birth defect present ^ 46 (3.5) 31 (4.5) 15 (2.5) 0.051 
Had low birthweight 38 (2.9) 25 (3.6) 13 (2.1) 0.14 
Term of 
pregnancy 
Preterm (< 37 wks) 9 (0.7) 6 (0.9) 3 (0.5) 
 
Early term (37-38 wks) 142 (10.9) 111 (16.0) 31 (5.1) <0.001* 
Full term (≥ 39 wks) 1153 (88.4) 575 (83.1) 578 (94.4) 
 
FGP consulted 
A 318 (24.4) 177(25.6) 141 (23.1) 
 
B 360 (27.6) 199 (28.8) 161 (26.3) 0.28 
C 371 (28.4) 192 (27.7) 179 (29.2) 
 
D 255 (19.6) 124 (17.9) 131 (21.4) 
 
^ Missing value for one participant  
900 
* p-value of  < 0.05 is considered to be significant
 
 
901 
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Table 5. (a) Incidence rates (IRs) of ILI and sARI cases for infant under 6 months, stratified by 902 
age groups and for the overall cohort. (b) Positive case numbers of influenza A, influenza B 903 
and RSV in the study and for sARI cases only, stratified by age groups and for the overall 904 
cohort. 905 
(a) 906 
Age group 
(weeks) 
ILI sARI 
No. of 
cases 
IR per 1,000 
person-days (95% 
CI) 
No. of 
cases 
IR per 1,000 person-
days (95% CI) 
0 - 7.9 46 9.10 (8.21 – 10.1) 80 21.3 (20.0 – 22.8) 
8 - 15.9 69 10.9 (10.0 – 11.9) 72 15.7 (14.7 – 16.9) 
16 - 24 131 26.8 (25.2 - 28.5) 103 25.8 (24.2 – 27.4) 
Overall 246 15.2 (14.5 - 15.8) 255 20.5 (19.7 – 21.3) 
 907 
(b) 908 
 909 
Age 
group 
(weeks) 
Total 
samples 
tested 
Influenza A Influenza B RSV 
Total cases 
(%) 
sARI cases 
only (%) 
Total cases 
(%) 
sARI cases 
only (%) 
Total cases 
(%) 
sARI cases 
only (%) 
0 - 7.9 54 2 (3.7) 0 (0.0) 1 (1.9) 0  3 (5.6) 3 (5.6) 
8 - 15.9 79 2 (2.5) 1 (1.3) 0 (0.0) 0 8 (10.1) 7 (8.9) 
16 - 24 136 13 (9.6) 1 (0.7) 2 (1.5) 0 14 (10.3) 7 (5.1) 
Overall 269 17 (6.3) 2 (0.7) 3 (1.1) 0 25 (9.3) 17 (6.3) 
  910 
 
 
47 
Table 6. Risk factor analysis results when comparing sARI cases and non-sARI among infants 911 
under 6 months. Covariates were chosen based on initial univariate analyses (Table 8). 912 
Estimates in bold indicate statistically significant covariates.  913 
Infant < 6 months and sARI 
cases 
Hazard ratio (95% C.I) 
Un-adjusted Adjusted 
Age group 
(weeks) 
0 - 7.9 1.05 (0.78 - 1.42) 1.03 (0.76 - 1.39) 
8 - 15.9 0.76 (0.55 - 1.04) 0.75 (0.55 - 1.04) 
16 - 24 1 (ref) 1 (ref) 
Gender 
Female 1 (ref) 1 (ref) 
Male 1.42 (1.09 - 1.85) 1.40 (1.07 - 1.83) 
Has birth defect^ 
No 1 (ref) 1 (ref) 
Yes 1.40 (0.86 - 2.28) 1.09 (0.57 - 2.11) 
Gestational age 
at delivery 
Full term 1 (ref) 1 (ref) 
Preterm 2.64 (1.28 - 5.44) 2.26 (0.83 - 6.16) 
Early term 1.10 (0.73 - 1.66) 1.10 (0.71 - 1.70) 
^ Missing value for one participant  914 
 
 
48 
Table 7. Characteristics of the ILI cases and non-ILI for the pregnant women cohort. 915 
Population characteristics ILI (%) non-ILI (%) p-value 
No. of pregnant women 
enrolled 
Total 174 (13.8) 1100 (87.3)   
2013/14 season 110 (63.2) 542 (49.3) 
<0.001* 
2014/15 season 64 (36.8) 558 (50.7) 
Age at enrolment (years) 
Median ± sd 29 ± 6.0 27 ± 6.0 
0.01** 
Range 17 - 44 16 - 44 
Educated at high-school level or lower 26 (14.9) 253 (23.0) 0.02** 
Employment status 
Employed 
#
 127 (73.0) 707 (64.3) 
0.04** Unemployed 39 (22.4) 292 (26.5) 
Student 8 (4.6) 101 (9.2) 
BMI category ^ 
Underweight (< 18.5) 8 (4.6) 44 (4.0) 
0.54 
Normal (18.5-24.9) 122 (70.5) 731 (66.5) 
Overweight (25-29.9) 37 (21.4) 263 (23.9) 
Obese (≥ 30) 6 (3.5) 62 (5.6) 
Household characteristics       
Type of household 
structure ^ 
Apartment 83 (47.7) 468 (42.6) 
0.2 Ger 75 (43.1) 481 (43.8) 
Private house 16 (9.2) 150 (13.6) 
Household size  
1 - 2 21 (12.1) 153 (13.9) 
0.78 3 - 4 99 (56.9) 603 (54.8) 
5 and above 54 (31.0) 344 (31.3) 
Young child present (< 2yrs) 14 (8.0) 122 (11.1) 0.29 
Kindergarten-age child present (2 - 5yrs) 78 (44.8) 417 (37.9) 0.09** 
School-age child  present (6 - 17yrs) 85 (48.9) 560 (50.9) 0.67 
Obstetrics characteristics       
Trimester at enrolment 
1st (0 - 13 weeks) 101 (58.0) 452 (41.1) 
<0.001** 2nd (14 - 26 weeks) 59 (33.9) 374 (34.0) 
3rd (≥ 27 weeks) 14 (8.1) 274 (24.9) 
Gestational age at 
enrolment 
Median ± sd 12.4 ± 7.7 16.6 ± 9.7 
<0.001** 
Range 2.0 - 34.0 1.7 - 41.0 
FGP consulted 
A 31 (17.8) 266 (24.2) 
0.07** 
B 52 (29.9) 263 (23.9) 
C 63 (36.2) 348 (31.6) 
D 28 (16.1) 223 (20.3) 
Has prior pregnancy 134 (77.0) 757 (68.8) 0.04** 
Has any co-morbidity ^^ 77 (44.3) 371 (33.7) 0.006** 
Classified as high risk pregnancy 98 (56.3) 511 (46.5) 0.02** 
#
 Includes employment in power stations, coal mining, agriculture, offices, schools and 
healthcare 
 ^ Missing value for one participant 
^^ Missing value for two participants 
* p-value of  < 0.05 is considered to be significant 
 ** Variable was included in Cox PH model 
  916 
 
 
49 
Table 8. Characteristics of the (a) ILI cases and non-ILI, and (b) sARI cases and non-sARI for the infants under 6 months cohort. 917 
Population characteristics ILI cases (%) Non-ILI (%) p-value sARI cases (%) Non-sARI (%) p-value 
No. of infants  < 6 
months enrolled 
Total 246 (18.9) 1103 (84.6)   255 (19.6) 1088 (83.4)   
2013/14 season 129 (52.4) 583 (52.9) 
0.96 
126 (49.4) 580 (53.3) 
0.35 
2014/15 season 117 (47.6) 520 (47.1) 129 (50.6) 508 (46.7) 
Male gender 125 (50.8) 571 (51.8) 0.84 149 (58.4) 551 (50.6) 0.03** 
Age at enrolment 
(days) 
Median ± sd 21 ± 34.3 11 ± 53.1 
<0.001** 
8  ± 39.5 12  ± 52.6 
0.01** 
Range 1 - 144 0 - 167 0 - 155 0 - 167 
Newborn characteristics             
Birth defect present ^ 10 (4.0) 39 (3.5) 0.83 14 (5.5) 32 (2.9) 0.06** 
Had low birthweight 6 (2.4) 33 (3.0) 0.83 11 (4.3) 27 (2.5) 0.17 
Term of pregnancy 
Preterm (< 37 weeks) 0 (0.0) 9 (0.8)   5 (2.0) 4 (0.4) 
0.03** Early term (37-38 weeks) 25 (10.2) 120 (10.9) 0.49 10 (3.9) 41 (3.8) 
Full term (≥ 39 weeks) 221 (89.8) 974 (88.3)   240 (94.1) 1043 (95.8) 
FGP consulted 
A 50 (20.3) 278 (25.2) 
0.002** 
63 (24.7) 268 (24.6) 
0.77 
B 88 (35.8) 291 (26.4) 64 (25.1) 302 (27.8) 
C 76 (30.9) 308 (27.9) 73 (28.6) 309 (28.4) 
D 32 (13.0) 226 (20.5) 55 (21.6) 209 (19.2) 
Household characteristics (For 2014/15 season only)           
Type of household 
structure 
Apartment 30 (25.6) 240 (46.2) 
<0.001** 
77 (59.7) 206 (40.6) 
<0.001** Ger 71 (60.7) 178 (34.2) 38 (29.4) 198 (39.0) 
Private house 16 (13.7) 102 (19.6) 14 (10.9) 104 (20.5) 
 Household size 
1 - 2 3 (2.6) 18 (3.4) 
0.78 
7 (5.4) 15 (3.0) 
0.20 3 - 4 55 (47.0) 225 (43.3) 62 (48.1) 221 (43.5) 
5 and more 59 (50.4) 277 (53.3) 60 (46.5) 272 (53.5) 
Young child present (< 2yrs) 12 (10.3) 43 (8.3) 0.61 18 (14.0) 36 (7.1) 0.02** 
Kindergarten-age child present (2 - 5yrs) 58 (49.6) 213 (41.0) 0.11 58 (45.0) 206 (40.6) 0.42 
School-age child  present (6 - 17yrs) 47 (40.2) 246 (47.3) 0.19 51 (39.5) 242 (47.6) 0.12 
** Variable was included in Cox PH model 
      ^ Missing value for one participant 
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Table 9. Risk factor analysis results when comparing ILI and non-ILI cases for pregnant women, in the (a) 2013/14 and (b) 2014/15 seasons. 918 
  
(a) 2013/14 season  (b) 2014/15 season  
Pregnant women and ILI 
Hazard ratio (95% C.I) Hazard ratio (95% C.I) 
Un-adjusted Adjusted Un-adjusted Adjusted 
Trimester at 
infection 
1st 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
2nd 0.55 (0.32 - 0.94) 0.57 (0.33 - 0.99) 0.44 (0.25 - 0.79) 0.42 (0.23 - 0.77) 
3rd 0.39 (0.23 - 0.65) 0.44 (0.26 - 0.74) 0.32 (0.17 - 0.59) 0.33 (0.17 - 0.62) 
Highest 
education 
attained 
College or higher 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
High school or lower 0.56 (0.35 - 0.89) 0.70 (0.40 - 1.22) 0.60 (0.22 - 1.60) 1.28 (0.31 - 5.36) 
Employment 
status 
Employed 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
Unemployed 1.00 (0.64 - 1.55) 1.20 (0.74 - 1.94) 0.43 (0.20 - 0.94) 0.49 (0.21 - 1.17) 
Student 0.67 (0.27 - 1.19) 1.10 (0.46 - 2.60) 0.25 (0.03 - 1.90) 0.19 (0.01 - 4.09) 
FGP 
A 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
B 1.33 (0.74 - 2.39) 1.37 (0.74 - 2.53) 1.68 (0.86 - 3.27) 1.48 (0.76 - 2.89) 
C 1.86 (1.09 - 3.15) 1.78 (1.04 - 3.05) 0.86 (0.42 - 1.80) 0.81 (0.41 - 1.59) 
D 1.47 (0.81 - 2.68) 1.57 (0.86 - 2.86) 0.67 (0.28 - 1.57) 0.69 (0.29 - 1.62) 
Age at enrolment 1.04 (1.01 - 1.07) 1.01 (0.97 - 1.06) 1.00 (0.96 - 1.04) 0.97 (0.91 - 1.03) 
Has any co-morbidity 0.96 (0.66 - 1.39) 0.88 (0.62 - 1.27) 1.98 (1.17 - 3.36) 2.05 (1.09 - 3.83) 
Classified as high risk pregnancy 1.46 (1.01 - 2.13) 1.27 (0.84 - 1.92) 1.24 (0.74 - 2.10) 1.08 (0.59 - 2.00) 
Has prior pregnancy 1.62 (1.02 - 2.58) 1.24 (0.72 - 2.14) 1.01 (0.57 - 1.78) 1.09 (0.55 - 2.15) 
Had kindergarten-age child (2-5 yrs) in 
household 
1.34 (0.92 - 1.93) 1.27 (0.88 - 1.84) 1.00 (0.61 - 1.66) 0.91 (0.54 - 1.54) 
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